To address this we separated the ABC-DLBCL cases into four groups, by using a contingency table approach divided by high and/or low expression of BATF and SPIB mRNA (top and bottom 50% of expression as threshold). The gene discussed is SPIB; the disease is diffuse large B-cell lymphoma.